SCHEMBL2332592

SCHEMBL2332592

CCCC(=O)c1[c]cccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B3 P37058 1/20 0.41
CES2 O00748 2/20 0.40
CES1 P23141 2/20 0.40
TSHR P16473 2/20 0.39
LMNA P02545 1/20 0.37
ALOX5 P09917 1/20 0.37
TP53 P04637 1/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
ALDH1A1 P00352 4/20 0.36
RECQL P46063 2/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 1/20 0.35
HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629579 0.89 HSD17B3 (0.44) HSD17B3CES2CES1LMNAALDH1A1
SCHEMBL5544087 0.87 MEN1 (0.47) HSD17B3CES2CES1ALDH1A1MAPT
SCHEMBL9564649 0.86 MEN1 (0.50) L3MBTL1HSD17B3CES2CES1LMNA
SCHEMBL9564615 0.86 MEN1 (0.50) L3MBTL1HSD17B3CES2CES1LMNA
SCHEMBL9564627 0.86 MEN1 (0.50) L3MBTL1HSD17B3CES2CES1LMNA
SCHEMBL9564618 0.86 MEN1 (0.50) L3MBTL1HSD17B3CES2CES1LMNA
SCHEMBL9564650 0.86 MEN1 (0.50) L3MBTL1HSD17B3CES2CES1LMNA
SCHEMBL9564658 0.86 MEN1 (0.50) L3MBTL1HSD17B3CES2CES1LMNA
SCHEMBL9564624 0.86 MEN1 (0.50) L3MBTL1HSD17B3CES2CES1LMNA
SCHEMBL9564643 0.86 MEN1 (0.50) L3MBTL1HSD17B3CES2CES1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105906591-A Synthesis method of 2-amino-gamma-butyrolactone hydrochloride 中国药科大学 2016-08-31 CN claimed
CN-102653543-A Preparation method, biological activity and application of 3-substituted type Jolkinolide compound UNIV CHINA PHARMA 2012-09-05 CN claimed
EP-0830349-B1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS DU PONT PHARM CO (US) 2000-03-22 EP claimed
US-5877312-A Method for preparing alkylating agents for their use for alkylating cyclic ureas DUPONT PHARMACEUTICALS COMPANY (US) 1999-03-02 US claimed
EP-0830349-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-03-25 EP claimed
US-5637780-A Method for preparing alkylating agents and their use for alkylating cyclic ureas THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-06-10 US claimed
EP-0767770-A1 METHOD FOR PREPARING ALKYLATING AGENTS AND THEIR USE FOR ALKYLATING CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-04-16 EP claimed
WO-1996039393-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-12 WO claimed
WO-1996000708-A1 METHOD FOR PREPARING ALKYLATING AGENTS AND THEIR USE FOR ALKYLATING CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-01-11 WO claimed
EP-2356979-B1 ANTI-WRINKLE AGENTS POLA CHEM IND INC (JP) 2017-10-25 EP disclosed
WO-2017117514-A1 DEUTERATED ITI-007 TUNG ROGER D (US) 2017-07-06 WO disclosed
EP-3173063-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2017-05-31 EP disclosed
EP-2514402-B1 PREVENTING OR AMELIORATING AGENT FOR PIGMENTATION POLA CHEM IND INC (JP) 2016-08-31 EP disclosed
CN-105906591-A Synthesis method of 2-amino-gamma-butyrolactone hydrochloride 中国药科大学 2016-08-31 CN disclosed
EP-0511879-A1 Pyrazine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-04 EP disclosed
EP-0335723-B1 ISOXAZOLE DERIVATIVES FOR USE AS CEREBRO-ACTIVE DRUGS AND CENTRAL MUSCLE RELAXANTS Sankyo Company Limited (JP) 1991-12-04 EP disclosed
EP-0420464-A2 3-Isoxazolone derivatives, their preparation and their therapeutic uses Sankyo Company Limited (JP) 1991-04-03 EP disclosed
EP-0335723-A1 Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants Sankyo Company Limited (JP) 1989-10-04 EP disclosed
EP-0192167-A1 Use of thio-substitued ketones as photoinitiators MERCK PATENT GmbH (DE) 1986-08-27 EP disclosed
US-4348410-A Cyclohexane carboxylic acid derivatives NIPPON CHEMIPHAR CO., LTD. (JP) 1982-09-07 US disclosed